With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Hedgehog & IGF Signaling through IRSI in Brain Development and Medulloblastoma||Memorial Sloan-Kettering Cancer Center / Anna Marie Kenney, PhD||Young Investigator Grants||2006||New York|
|Mechanisms of leukocyte recruitment to the lung during idiopathic pneumonia syndrome following allogeneic bone marrow transplantation.||Regents of the University of Michigan / Sung Won Choi, MD||Young Investigator Grants||2006||Michigan|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma||Children's Hospital of Philadelphia / Naomi Balamuth, MD||Young Investigator Grants||2006||Pennsylvania|
|HMG-I/Y in pediatric Leukemia and Lymphoma.||The Johns Hopkins University School of Medicine / Linda Smith Resar, MD||Innovation Grants||2006||Maryland|
|Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma||The Pennsylvania State University / Ken Lucas, MD||Innovation Grants||2006||Pennsylvania|
|Mediators of Metastasis in Alveolar Rhabdomyosarcoma.||University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD||Young Investigator Grants||2006||Texas|
|MTG-16 Regulation by Phosphorylation||Vanderbilt University Medical Center / Michael Engel, MD, PhD||Young Investigator Grants||2006||Tennessee|
|Pediatric Oncology Translational Research Program.||Vanderbilt University Medical Center / James Whitlock, MD||Phase I/II Infrastructure Grants||2006||Tennessee|
|Pax3-FKHR targets that enable bypass of cellular senescence in rhabdomyosarcoma.||Duke University Medical Center / Corinne Mary Linardic, MD, PhD||Young Investigator Grants||2006||North Carolina|